Large Vessel Vasculitis for the Nurse Practitioner Licensing Exam
Large Vessel Vasculitis
Large vessel vasculitis involves inflammation of the aorta and its major branches, with two primary types:
Giant Cell Arteritis (GCA) and
Takayasu Arteritis (TA). Both conditions can lead to severe ischemic complications if untreated.
Giant Cell Arteritis (GCA)
- Definition:
- Also known as temporal arteritis, GCA affects the aorta and cranial arteries, often involving the temporal arteries.
- Closely associated with polymyalgia rheumatica (PMR).
- Epidemiology:
- Typically affects adults >50 years, with higher prevalence in women and those of Northern European ancestry.
- Clinical Presentation:
- Symptoms: Severe headache, scalp tenderness, jaw claudication (pain with chewing), and visual disturbances (transient or permanent vision loss).
- PMR Association: Often coexists with PMR, causing pain and stiffness in the shoulders and hips.
- Diagnosis:
- ESR and CRP: Elevated inflammatory markers.
- Temporal Artery Biopsy: Gold standard, showing mononuclear cell inflammation and giant cells.
- Imaging: Ultrasound of the temporal artery may show a “halo sign.”
- Management:
- Corticosteroids: High-dose prednisone is used to prevent vision loss.
- Tocilizumab: An IL-6 inhibitor, used in refractory or relapsing cases.
Takayasu Arteritis (TA)
- Definition:
- A granulomatous vasculitis affecting the aorta and its branches, often resulting in narrowed or occluded arteries.
- Known as “pulseless disease” due to reduced pulses in affected areas.
- Epidemiology:
- Common in young women under 40, especially in Asian and Latin American populations.
- Clinical Presentation:
- Symptoms: Fatigue, limb claudication (especially arms), diminished pulses, blood pressure discrepancies, and hypertension secondary to renal artery stenosis.
- Diagnosis:
- ESR and CRP: Elevated markers of inflammation.
- Imaging: MRI or CT angiography to visualize stenosis or occlusion in large vessels.
- Management:
- Corticosteroids: Primary treatment, often followed by tapering.
- Immunosuppressive Agents: Methotrexate or azathioprine for steroid-sparing effects.
Key Points
- Giant Cell Arteritis (GCA):
- Typically in adults >50 with symptoms including headache, jaw pain, visual loss, and PMR association.
- Diagnosed by biopsy and managed with high-dose steroids; tocilizumab for refractory cases.
- Takayasu Arteritis (TA):
- Affects young women with limb claudication, reduced pulses, and blood pressure differences.
- Diagnosed by imaging; treated with corticosteroids and immunosuppressants.
- Complications:
- GCA: Risk of vision loss and aortic aneurysm.
- TA: Hypertension, limb ischemia, aneurysm formation.